Jpmorgan Chase & CO Imago Bio Sciences, Inc. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$15.03 - $35.96 $10,385 - $24,848	-691 Reduced 4.19%	15,807 $569,000
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $13,810 - $19,032	976 Added 6.29%	16,498 $248,000
Q2 2022 Aug 11, 2022	SELL	$11.81 - $20.92 $557,491 - $987,528	-47,205 Reduced 75.25%	15,522 $208,000
Q1 2022 May 11, 2022	BUY	$16.97 - $25.0 $949,709 - $1.4 Million	55,964 Added 827.5%	62,727 $1.21 Million
Q4 2021 Feb 10, 2022	BUY	$16.22 - $29.69 $49,130 - $89,931	3,029 Added 81.12%	6,763 $161,000
Q3 2021 Nov 12, 2021	BUY	$16.0 - $28.84 $59,744 - $107,688	3,734 New	3,734 $75,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.